Wasatch Advisors Inc Intra Cellular Therapies, Inc. Transaction History
Wasatch Advisors Inc
- $19.9 Billion
- Q4 2024
A detailed history of Wasatch Advisors Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 3,248,821 shares of ITCI stock, worth $416 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
3,248,821
Previous 3,848,588
15.58%
Holding current value
$416 Million
Previous $281 Million
3.58%
% of portfolio
1.36%
Previous 1.4%
Shares
31 transactions
Others Institutions Holding ITCI
# of Institutions
415Shares Held
88.5MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.24 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$809 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$656 Million0.03% of portfolio
-
Norges Bank Oslo, Q83.21MShares$411 Million0.04% of portfolio
-
Invesco Ltd. Atlanta, GA3.08MShares$394 Million0.05% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.1B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...